Pazopanib-induced organizing pneumonia in a patient with leiomyosarcoma: A case report
Pazopanib, a multityrosine kinase inhibitor used for treating malignant soft tissue tumors, rarely causes adverse events associated with the respiratory system. We report a case of a 73-year-old male with leiomyosarcoma treated with pazopanib. Four months after treatment initiation, chest computed t...
Main Authors: | Chie Watanabe, Jun Miyata, Kotoba Esaki, Ryohei Suematsu, Tomoya Sano, Takayuki Yamamoto, Hisashi Sasaki, Yohei Maki, Yoichi Tagami, Yoshifumi Kimizuka, Yuji Fujikura, Keiichi Ito, Akihiko Kawana |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120301878 |
Similar Items
-
Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report
by: Kayo Inoue, et al.
Published: (2016-08-01) -
Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma
by: Steven Attia, et al.
Published: (2015-05-01) -
Pazopanib-Induced Severe Acute Pancreatitis
by: Kazumichi Kawakubo, et al.
Published: (2015-08-01) -
Pazopanib in the management of advanced soft tissue sarcomas
by: Cranmer LD, et al.
Published: (2016-06-01) -
Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature
by: Yoshiro Nakahara, et al.
Published: (2017-04-01)